Emerging
therapeutic treatments based on the production of proteins
by delivering mRNA have become increasingly important in recent times.
While lipid nanoparticles (LNPs) are approved vehicles for small interfering
RNA delivery, there are still challenges to use this formulation for
mRNA delivery. LNPs are typically a mixture of a cationic lipid, distearoylphosphatidylcholine
(DSPC), cholesterol, and a PEG-lipid. The structural characterization
of mRNA-containing LNPs (mRNA-LNPs) is crucial for a full understanding
of the way in which they function, but this information alone is not
enough to predict their fate upon entering the bloodstream. The biodistribution
and cellular uptake of LNPs are affected by their surface composition
as well as by the extracellular proteins present at the site of LNP
administration, e.g., apolipoproteinE (ApoE). ApoE,
being responsible for fat transport in the body, plays a key role
in the LNP’s plasma circulation time. In this work, we use
small-angle neutron scattering, together with selective lipid, cholesterol,
and solvent deuteration, to elucidate the structure of the LNP and
the distribution of the lipid components in the absence and the presence
of ApoE. While DSPC and cholesterol are found to be enriched at the
surface of the LNPs in buffer, binding of ApoE induces a redistribution
of the lipids at the shell and the core, which also impacts the LNP
internal structure, causing release of mRNA. The rearrangement of
LNP components upon ApoE incubation is discussed in terms of potential
relevance to LNP endosomal escape.